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Advances in paediatric urology 
David A Diamond, Ivy H Y Chan, Andrew J A Holland, Michael P Kurtz, Caleb Nelson, Carlos R Estrada Jr, Stuart Bauer, 
Paul K H Tam 
Paediatric urological surgery is often required for managing congenital and acquired disorders of the genitourinary 
system. In this Series paper, we highlight advances in the surgical management of six paediatric urological disorders. 
The management of vesicoureteral reflux is evolving, with advocacy ranging from a less interventional assessment 
and antimicrobial prophylaxis to surgery including endoscopic injection of a bulking agent and minimally invasive 
ureteric reimplantation. Evidence supports early orchidopexy to improve fertility and reduce malignancy in boys with 
undescended testes. A variety of surgical techniques have been developed for hypospadias, with excellent outcomes 
for distal but not proximal hypospadias. Pelvi-ureteric junction obstruction is mostly detected prenatally; indications 
for surgery have been refined with evidence, and minimally invasive pyeloplasty is now standard. The outlook for 
patients with neurogenic bladder has been transformed by a combination of clean intermittent catheterisation, 
algorithms of diagnostic investigations, and innovative medical and surgical therapies. Posterior urethral valves are 
associated with considerable mortality; fetal diagnosis allows stratification of candidates for intervention, but ongoing 
bladder dysfunction in patients after valve ablation remains a cause of long-term morbidity. 
Introduction 
A substantial portion of paediatric urology entails surgical 
correction of congenital and acquired disorders of the 
genitourinary system. With rapid developments in clinical 
and basic research, from prenatal diagnosis and minimally 
invasive surgery to evidence-based clinical guidelines, 
paediatric urology has become a major subspecialty. In this 
Series paper, we describe the exciting advances and 
innovations in the surgical management of six important 
paediatric urological disorders. Although minimally 
invasive surgery and innovative surgical techniques have 
improved early outcomes of common, non-lethal disorders 
such as vesicoureteral reflux, undescended testes, and the 
mild forms of hypospadias and pelvi-ureteric junction 
obstruction, most paediatric urological disorders, 
especially the severe anomalies, are associated with longterm 
morbidity. Treatment of neurogenic bladder 
exemplifies the advantages of a multidisciplinary approach 
with medical and innovative surgical therapies. Although 
fetal and neonatal diagnosis and treatment have improved 
survival in children with rare, complex, and life-threatening 
diseases such as posterior urethral valve, the management 
of long-term sequelae remain challenging. 
Vesicoureteral reflux 
Vesicoureteral reflux is the retrograde flow of urine from 
the bladder to the ureter (or ureters), affecting 1–25% of 
children and predisposing them to urinary tract infection 
and renal scarring. A comprehensive review is available 
elsewhere;1 here we focus on recent research findings. 
Although vesicoureteral reflux resolves in many cases, 
the ability to predict resolution in a given patient is 
limited. Vesicoureteral reflux grade is important. 
Multivariable models incorporating a range of factors, 
including vesicoureteral reflux index,2 normograms, and 
ureteral diameter, might increase prognostic accuracy 
compared with vesicoureteral reflux grade alone, but the 
results for an individual patient can differ substantially 
between models, warranting caution in their clinical 
application. 
Vesicoureteral reflux has a genetic basis, with 
concordance in identical twins approaching 100%, and a 
27% prevalence in siblings.3 Although numerous genetic 
loci have been associated with vesicoureteral reflux, 
progress in identifying specific genetic targets for 
diagnosis or therapy is limited because of the 
heterogeneous genetic pattern.4 New genetic techniques 
are rapidly advancing discovery of human genetic 
contributors to congenital anomalies of the kidney and 
urinary tract, including vesicoureteral reflux. 
The UK’s National Institute for Health and Clinical 
Excellence and the American Academy of Pediatrics5 
recommend a less interventional approach to assessing 
children with febrile urinary tract infection, with deferral 
of micturating cystourethrography until urinary tract 
infection recurrence. The rationale is to avoid 
overdiagnosis and overtreatment of indolent disease. 
One principle is that ultrasound serves as an initial 
screen to identify children who should immediately 
proceed to further imaging by micturating 
cystourethrography, but there are limitations to using 
ultrasound to screen for vesicoureteral reflux, and a 
normal ultrasound does not exclude high-grade 
vesicoureteral reflux.6 Many specialists contest the 
conservative approach and warn that leaving 
vesicoureteral reflux undiagnosed puts a subset of 
children at increased risk of additional morbidity and 
potential renal damage associated with recurrent urinary 
tract infection. 
When cystography is indicated, contrast-enhanced 
voiding sonography is increasingly seen as an alternative 
to fluoroscopic or radionuclide cystography. Results from 
several centres show comparable rates of detection of 
vesicoureteral reflux using this technique,7 but the quality 
and completeness of information provided in reports 
varies, and some variation also can be seen in the same 
patient. Awareness of variations and standardisation is 
much needed.8 
The screening of asymptomatic siblings is controversial. 
According to guidelines3 released in 2010, screening of 
siblings is an option, but an observational approach 
could also be taken. In view of the relatively indolent 
nature of most sibling vesicoureteral reflux and the 
number of patients needed to screen to prevent adverse 
outcomes, the potential for benefits of screening siblings 
is low.9 
For the medical treatment of children with 
vesicoureteral reflux, data from the RIVUR10 randomised 
controlled trial showed that antimicrobial prophylaxis 
with trimethoprim plus sulfamethoxazole reduced the 
incidence of recurrent urinary tract infection by about 
50% in children with vesicoureteral reflux or a history of 
vesicoureteral reflux. Findings from a subsequent metaanalysis11 
confirmed a significant effect of antibiotic 
prophylaxis. Antibiotic prophylaxis has not been shown 
to reduce renal scarring, but no study has been adequately 
powered to assess this outcome. However, strong 
evidence does suggest that a febrile urinary tract infection 
is associated with risk of scarring, and early treatment of 
febrile urinary tract infection can decrease the incidence. 
Although open ureteral reimplantation is the gold 
standard for surgery, many centres have pursued roboticassisted 
laparoscopic reimplantation (figure 1). Adoption 
has been limited because of concerns with higher 
complication rates and lower success rates than for open 
reimplantation,12 although favourable results have been 
reported from a series of robot-assisted procedures.13 
Pneumovesicoscopic 
reimplantation (figure 2) has been 
used as a minimally invasive alternative in several centres,14 
and although the short-term results of open and 
pneumovesical approaches were comparable, patients 
undergoing pneurovesicoscopic ureteral reimplantation 
had shorter hospital stays but longer operating times than 
patients undergoing open ureteral reimplantation. Results 
of a follow-up study confirmed satisfactory intermediate 
outcomes of pneumovesical ureteric reimplantation.15 
Whether pneumovesicopic techniques will become more 
widely adopted remains to be seen since the increasing use 
of robotic-assisted transperitoneal approaches could limit 
their uptake in affluent communities. Endoscopic therapy 
(primarily with dextranomer hyaluronic acid copolymer; 
figure 3) is a widely used alternative to surgical 
reimplantation. In the Swedish reflux trial,16 antibiotic 
prophylaxis and endoscopic treatment were superior to 
surveillance along in preventing recurrent urinary tract 
infection. Endoscopic treatment is less invasive than 
ureteric reimplantation but also has a lower success rate in 
correcting vesicoureteral reflux.17 Boys younger than 
6 months with vesicoureteral reflux might benefit from 
circumcision as this procedure is associated with a 
ten-times reduction in the risk of urinary tract infection.18 
Undescended testes 
Undescended testes is considered the most common 
genital anomaly in boys, with a reported incidence that 
varies between 0・5% and 9% (1–5% in most reports). 
This variation reflects the clinical nature of the diagnosis, 
the patient population studied, and the inclusion or 
otherwise of acquired undescended testes.19 The apparent 
increase in incidence suggested in some reports probably 
reflects a combination of enhanced screening, improved 
survival of premature infants, and strengthened 
recognition of the ascending testis syndrome.19 
Ultrasound, although often used, has very little value in 
the diagnosis and management of undescended testes. 
Most cases appear congenital, but an important group of 
cases present later in childhood, either as a result of 
delayed diagnosis or development of ascending testis 
syndrome in a previously descended testis19,20,21—hence 
the importance of follow-up of boys with retractile testes. 
Bilateral, non-palpable testes at birth are rare and should 
prompt endocrinological and genetic assessment to 
exclude congenital adrenal hyperplasia or bilateral 
vanishing testes. A cases of acquired undescended testes 
occur as a result of postsurgical adhesions complicating 
inguinal surgery or reascent after orchidopexy. 
With increasing evidence that early surgery for 
undescended testes improves subsequent fertility (which 
is particularly impaired in men with bilateral 
undescended testes), reduces risk of torsion, has 
cosmetic advantages, and improves detection of any 
future malignancy,22 the American Urological Association 
and the European Association of Urology advocate 
orchidopexy at 6–18 months of age.23,24 Unfortunately, 
many boys are still not having early surgery,25 and 
awareness of the need for early referral and timely 
surgical intervention should be improved (figure 4). 
Fertility is typically assessed with surrogate markers such 
as testicular volume, testicular histology, and semen 
analysis.26,27 In one study,26 normal sperm counts were 
reported in 96% of patients who had surgical treatment 
before 1 year of age, compared with 75% of patients who 
had surgery when aged 1–2 years. Hormonal treatment is 
controversial but might have a role in selected cases with 
a high risk of infertility.28 
The testes undergo a critical phase of development in 
the first 6 months of life, with selected gonocytes 
transforming into adult dark-spermatogonia for future 
spermatogenesis and non-transforming gonocytes 
undergoing apoptosis.29 Adult dark-spermatogonia seem 
to be crucial determinants of future sperm counts and 
potential fertility.27 Although the overall risk of 
malignancy in adult men who had early surgery for 
undescended testes is 1・6–7・5 times the baseline 
prevalence, this prevalence is known to increase 
2・9–32 times in men who had surgery when they were 
older than 10 years.22,30,31 Persistent non-transforming 
gonocytes might be the originating cells of testicular 
malignancies in men with undescended testes. To 
enhance fertility and reduce malignancy, there is an 
argument for even earlier surgery at 3 months of age, but 
this option must be assessed in long-term studies. 
Most boys with palpable undescended testes will have 
an open, inguinal orchidopexy, with the testes placed in a 
scrotal, subdartos pouch. Minimally invasive surgery is 
appropriate for boys with impalpable undescended 
testes, and parascrotal incision is used for low 
undescended testes. Outcomes from these different 
approaches will depend on the initial position of the 
testis, the mobility and length of the testicular vessels, 
surgery has transformed the ability to assess and manage 
impalpable or intra-abdominal undescended testes. The 
traditional Fowler–Stephens staged orchidopexy, with 
initial division of the testicular vessels to stimulate 
collateral circulation through gubernacular vessels and 
the artery to the vas, followed by a delayed second-stage 
orchidopexy, could be readily performed laparoscopically 
as a day-case procedure, with reported atrophy of 2–33%.32 
With outcomes now equivalent to those of testicular 
autotransplantation, attention has moved to the 
possibility of a one-stage procedure.33 Establishing 
equivalence of orchidopexy outcomes remains very 
difficult without consistent, objective assessment of 
initial testicular position and its mobility at the time of 
surgery.19,22 
Hypospadias 
The incidence of hypospadias (1/300 newborn boys) was 
once thought to be increasing, with a doubling of 
incidence in the USA in the 1970s and 1980s. However, 
European and Australian data have indicated a more 
stable incidence in the past 10 years.34,35 The data reported 
worldwide remain conflicting, and reported incidence 
ranges from 0・6 to 34・2 per 10 000 live births.36 Increasing 
awareness of the disease, putative effects from 
environmental endocrine disruptors, and differing study 
methodologies might all have contributed to the 
variations in reported incidence. 
The aetiology of hypospadias seems to be multifactorial. 
Genetic anomalies are likely to be important, but most 
mutations have been identified comparatively infrequently 
and typically in the most severe or syndromal cases. Distal 
hypospadias, the most common type, is probably 
polygenic or multifactorial.37 Limited epidemiological 
evidence38 suggests a small increased risk with prenatal 
and postnatal exposure to environment-disrupting 
chemicals such as pesticides, cosmetics, industrial 
chemicals, and some medications. In a systematic review 
from 2012,37 low birthweight, maternal hypertension, and 
pre-eclampsia were consistently implicated in 
hypospadias. 
Surgical repair aims to reconstruct the urethra, correct 
chordee, and improve cosmesis with minimal morbidity. 
Many techniques have been described, but no clear 
single best method of urethroplasty has been identified. 
Choice of method largely depends on a comparatively 
subjective appraisal of the patient’s anomalous anatomy 
(including location of the urethral meatus and severity of 
chordee) and the surgeon’s experience and preference.39,40 
Repair might take a one-stage or two-stage approach, 
using the patient’s own preputial skin for reconstruction 
in most cases. Other tissues used in reconstruction 
include buccal mucosa, tunica vaginalis flap, scrotal skin, 
and bladder or tongue mucosa. 
The single-stage tubularised incised plate method, first 
described by Snodgrass39 and with complication rates 
of 7% and 11% in distal and proximal hypospadias, 
respectively, is an effective and popular option, especially 
for distal hypospadias. In a 2012 systematic review,41 
tubularised incised plate and Mathieu (meatal-based 
flap) methods (figure 5) for repair of distal hypospadias 
were compared; although the complication rates of both 
procedures were low, repair by the tubularised incised 
plate method was associated with the lowest incidence of 
urethra-cutaneous fistula, whereas Mathieu repair had 
the lowest rate of meatal stenosis. 
Preference of repair method for proximal hypospadias 
varies, but staged urethroplasty is preferred by nearly 
half of surgeons, particularly in the presence of severe 
chordee. Other common techniques include the extended 
tubularised incised plate method, with or without a graft, 
or an onlay procedure. Irrespective of the method, 
surgical repair of proximal hypospadias remains 
challenging: in one referral centre with a large patient 
volume, reoperation was required in up to 50% of 
patients, with urethro-cutaneous fistulas occurring in up 
to 30% of cases.42 Operative complications are reduced 
substantially with increasing surgical experience.43 
Operations for hypospadias are usually done within the 
first 2 years of life. Parents commonly ask about long-term 
function and future fertility. Outcome remains difficult to 
measure objectively, with changing surgical techniques in 
the past 30–40 years and inadequate data on long-term 
follow-up. Patients with distal hypospadias generally have 
low complication rates, with acceptable long-term 
functional and cosmetic outcomes. In a systematic review 
of long-term outcomes,44 lower urinary tract symptoms 
such as a weak stream, dribbling, or spraying were twice 
as common in adult men who had hypospadias repair 
than in the control group. In a 2009 study,45 semen quality 
did not differ between men with isolated hypospadias and 
men in a control group, yet the paternity rate was 
lower (24%) in men who had surgery for hypospadias than 
the general age-matched population (29%). Paternity and 
sexual function might be related to psychosexual 
development, and this seems to particularly affect boys 
with proximal hypospadias. More patients with 
hypospadias (33%) than in a general population (13%) 
reported an inhibition in seeking sexual contact.46 Patients 
with severe hypospadias remain much less satisfied with 
penile appearance than patients with hypospadias in 
general or controls.44 For the subset of patients with severe 
hypospadias, objective, validated assessment and good 
understanding of long-term outcome and function in 
adult life. 
Pelvi-ureteric junction obstruction 
Antenatal hydronephrosis is found in up to 4・5% of all 
pregnancies, making it one of the most common 
urological abnormalities. Non-operative management 
will fail in about a third of patients with high-grade 
hydronephrosis (Society for Fetal Urology grade 3–4) due 
to pelvi-ureteric or ureteropelvic junction obstruction, 
and the anterior–posterior diameter of the renal pelvis 
appears to be the strongest predictor of the need for 
intervention postnatally.47 Various cutoffs have been 
proposed, ranging from 16 mm48 to 24 mm,47 with variable 
sensitivity and specificity. Conservative management for 
high-grade hydronephrosis even in the first 12 months of 
age can be associated with some loss of renal function.49 
New schematics in classifying antenatal hydronephrosis 
by ultrasound, such as the upper tract dilation system, 
have been proposed. In some studies, the upper tract 
dilation system could not discriminate operative from 
non-operative candidates,50 whereas in other studies, the 
upper tract dilation system has been found to be more 
predictive.51 
The costs associated with imaging in terms of 
discomfort, time spent by the patient and family, and 
radiation exposure in nuclear renography creates a 
tremendous opportunity for urinary biomarkers in a 
diagnostic algorithm to select the patients needing 
surgical correction. Urinary concentration of molecular 
markers for kidney injury or adhesion, growth factors, 
and cytokines have been used in studies, but issues with 
the heterogeneous timing of assessment and sample size 
limit their applicability as predictive markers.52 An 
unbiased examination of the urinary proteome will yield 
even more information from a broad sample of patients; 
for example, a screen of 1100 urinary proteins yielded 
76 candidate proteins with diverse functions in 
inflammation, kidney cell adhesion, leucocyte migration, 
vasculogenesis, and carbohydrate metabolism.53 Further 
studies could earn such a panel of biomarkers a place in 
a diagnostic algorithm. Functional magnetic resonance 
urography is a radiation-free way of assessing renal 
function, and although this technology offers an excellent 
5% intraobserver and interobserver variability, issues of 
variability seem to be magnified in the infant population.54 
Beyond infancy, minimally invasive surgery for pelviureteric 
junction repair (figure 6) is becoming 
increasingly popular, especially in school-aged children.55 
A definitive benefit of laparoscopy compared with 
traditional open repairs in terms of cost, reduction in 
complication, or shortened hospital stay has been 
difficult to demonstrate, and results of a single-centre 
randomised trial56 showed clinical equivalence between 
the two methods, with the disadvantage of a 17 min 
longer operative time in the minimally invasive group 
(p<0・01) offset by the advantage of a 2・3 h shorter 
hospital stay (p=0・02). Outcomes described in singlecentre 
reports remain heterogeneous, especially for 
laparoscopy procedures, without details such as whether 
the Anderson–Hynes dismemberment was accomplished 
or other forms of plastic operations on the pelvi-ureteric 
junction were employed. However, even for the failed 
pyeloplasty, minimally invasive revision is safe and 
potentially more efficacious than open repair.57 The 
simple surgical displacement of a crossing vessel, which 
avoids a sutured anastomosis, is an attractive laparoscopic 
option that has been successful in some cases58 but 
carries the risk of leaving intrinsic obstruction 
unrelieved.59 
In affluent communities, robotic assistance is more 
common than laparoscopy alone, perhaps because of 
ease of suturing. The standard transperitoneal robotic 
approach leaves a well hidden umbilical scar, an 
ipsilateral lower quadrant scar, and a epigastric scar that 
can be cosmetically troublesome. An alternative robotic 
approach leaves an umbilical scar and two lower quadrant 
incisions at the level of a Pfannenstiel incision, which 
patients have been shown to prefer.60 Further efforts are 
being made by surgeons to decrease surgical scars with 
conventional and robotic single-incision pyeloplasty.61,62 
Infants will qualify for a standard robotic procedure 
when they have a pubis-to-xyphoid distance of more than 
15 cm, which is generally reached by 6 months of age if 
full term.63 
Neurogenic bladder 
Neurogenic bladder affects 1・5–2 babies per 10 000 livebirths. 
The challenge for the paediatric surgical specialist 
is to protect renal function and achieve urinary 
continence. The most common cause of paediatric 
neurogenic bladder is spina bifida. Other congenital 
causes include caudal regression and anorectal 
malformations. Acquired causes include spinal cord 
injury (trauma, infection, or tumour), extensive pelvic 
surgery, or CNS insults.64 Renal failure was once the most 
common cause of death in young adults with spina 
bifida, but modern management has transformed the 
long-term outlook, although many challenges remain. 
No consensus guidelines exist for the management of 
paediatric neurogenic bladder. In 2012, the International 
Children’s Continence Society provided recommendations65 
for the management of neurogenic bladder 
in children, and the US Centers for Disease Control and 
Prevention (CDC) convened an expert group to develop 
protocolised management.66 Patient recruitment began 
in 2015, and results are expected by 2020. This effort is in 
direct response to the known and substantial variability 
in the management of these patients.67 Although a more 
conservative policy exists, the following recommendations 
are illustrative of a proactive approach based on the belief 
that renal and bladder deterioration relies can be 
prevented with close and consistent follow-up. 
Early urodynamic studies and, if indicated, clean 
intermittent catheterisation and anticholinergic therapy, 
are protective against renal deterioration. External 
urethral sphincter function determines whether a 
patient’s bladder and sphincter are synergic or 
dyssynergic and therefore whether the patient is at risk of 
renal deterioration. Since this status is most likely to 
change in the first few years of life, patients should 
undergo urodynamic studies every 6 months during the 
first 2 years of life, yearly when aged 2–5 years, and on an 
individualised basis thereafter. An ultrasound of the 
kidneys and bladder is obtained at least on a yearly basis, 
with emphasis on renal anatomy. Data from urodynamic 
studies suggest that bladder wall thickness has little 
association with bladder function, emphasising the 
absence of alternatives to invasive testing.68 A micturating 
cystourethrogram should be obtained in infants with 
dyssynergy or upper urinary tract dilation if video 
urodynamic study facilities and capability are not 
available. Finally, the CDC protocol recommends a 
dimercaptosuccinic acid scan at 3 months and 5 years of 
age to assess for renal scarring.65 
Prenatal closure of spina bifida has recently been 
described and is being done in a limited number of 
centres in the USA.69 Initial findings suggest reduced 
rates of ventriculoperitoneal shunting and improved 
ambulation. Some data suggest that bladder function in 
patients who have prenatal closure might not be different 
from patients closed postnatally,70 but further follow-up is 
needed. 
The mainstay of medical management of neurogenic 
bladder is anticholinergic therapy.71 Oxybutynin chloride is 
the most widely used anticholinergic and is effective in 
neurogenic bladder treatment by increasing capacity, 
lowering urinary storage pressures, and abolishing 
overactive contractions.72 Alternative options for patients 
with overactive bladder contractions who are intolerant or 
refractory to anticholinergic therapy include mirabegron, 
a β3-adrenoceptor agonist, and gabapentin. If urodynamic 
studies reveal inadequate urethral resistance, 
α-sympathomimetic agents are added. There is often close 
association between bladder and bowel dysfunctions so an 
effective bowel-management programme for constipation 
and faecal incontinence should also be in place. 
Surgical options must be considered when medical 
management has failed.73 Classically, bladder 
augmentation by enterocystoplasty is definitive, but this 
method causes substantial short-term and long-term 
complications. In the rare case where a patient has a 
grossly dilated ureter associated with a non-functioning 
or minimally functioning kidney, a ureterocystoplasty 
can be considered, in either an open or laparoscopic 
manner.74 This technique eliminates several risks 
associated with enterocystoplasty.75 The use of botulinum 
toxin injected endoscopically into the bladder is an 
alternative option.76 Patient selection for botulinum 
therapy seems to be crucial; although effective in 
improving overactive contractions, botulinum therapy is 
ineffective in the management of fibrotic, poorly 
compliant bladders.76 
Tissue engineering has the potential to provide off-theshelf 
tissues for reconstructive surgery. To date, 
pioneering techniques that showed short-term efficacy 
have failed to show long-term success,77,78 but intensive 
efforts to develop reliable tissue engineering-based 
options continue and are promising. 
In patients for whom intermittent catheterisation via 
urethra is difficult or impossible, a continent 
catheterisable channel using appendix, reconfigured 
bowel, or ureter is an important tool in the paediatric 
surgeon’s armamentarium.79 
Treating sphincter weakness incontinence continues to 
be challenging; the effectiveness of bladder outlet 
procedures is highly variable, and when done without 
augmentation, cystoplasty might expose the upper tracts 
to increased pressures and lead to adverse outcome.80 
Overall, the way children with neurogenic bladder are 
managed has improved dramatically in the past 40 years. 
An astounding number of patients now live into 
adulthood. This advance has been made possible by close 
follow-up, the advent of clean intermittent catheterisation, 
reliable urodynamic studies, drugs that modulate bladder 
function, and surgical techniques that have been 
promoted and refined in the past few decades. 
Posterior urethral valves 
With an incidence of about 1/5000 newborn boys, 
posterior urethral valves are the most common cause of 
congenital lower urinary tract obstruction (LUTO). 
Posterior urethral valves are associated with high fetal 
and neonatal mortality (30%) and considerable lifelong 
morbidity. In severe cases, the disorder can lead to 
anhydramnios and pulmonary dysplasia during the 
canalicular phase of lung development. Abnormal renal 
development persists into childhood and adolescence: 
30–42% of patients develop end-stage renal failure, 
making posterior urethral valves the most common 
cause for paediatric renal transplantation. Some patients 
will develop bladder dysfunction. 
Recent advances in treatment concern fetal diagnosis 
and management. LUTO is increasingly recognised as a 
spectrum of diseases, and candidacy for fetal intervention 
varies accordingly.81 Patients with stage I disease (mild) 
present with normal amniotic fluid volume and fetal 
kidneys that are normal in echogenicity; no intervention 
is necessary at this stage. At the other end of the 
spectrum, patients with stage III disease (severe) present 
with oligohydramnios or anhydramnios and signs of 
abnormal fetal renal function (ie, renal dysplasia, cortical 
cysts, unfavourable fetal urinary biochemistry); 
intervention at this stage is controversial. Patients with 
stage II disease (severe) present with oligohydramnios or 
anhydramnios and severe bilateral hydronephrosis, but 
fetal renal function might be preserved (ie, no renal cysts 
or dysplasia, and favourable fetal urine biochemistry); 
experts suggest intervention and shunting at this stage 
could double the odds of survival.82 
Intervention has traditionally taken the form of 
vesicoamniotic shunting, percutaneously placing a 
double-coiled plastic tube with one coil in the fetal 
bladder and the other in the amniotic space. Little has 
changed in shunt design since the 1980s, and clogging or 
shunt dislodgement cause problems leading to the need 
for recurrent intervention, with risks of rupture of 
membranes assumed each time.83 Outcomes of a large 
trial82 suggest a 30% device-related complication rate. 
There was initial enthusiasm for fetoscopic ablation of 
posterior urethral valves because it addressed the 
problem definitively without issues of dislodgment. 
Although fetal cystoscopy is accurate for diagnosis, its 
therapeutic effectiveness compared with shunting has 
not been proven.84 Therapeutic fetoscopy is not applicable 
for all causes of LUTO (ie, urethral atresia), and fetal 
valve ablation risks urethral and adjacent organ injury85 
because laser energy can travel posteriorly. Bypassing the 
fetus entirely, serial amnioinfusion to restore amniotic 
fluid volume, either percutaneously or with an infusion 
port, has been proposed. This procedure has been 
successful technically but is still at an early stage of 
study.86 
Postnatally, it is crucial to determine precisely the 
cause of bladder-outlet obstruction. Ultrasound and 
fluoroscopic micturating cystourethrography are 
standard diagnostic investigations, although their 
performance characteristics are currently unassessable.87 
Just as in vesicoureteral reflux, ultrasound-based contrast 
agents have the potential to supplant fluoroscopic 
studies. Findings in early reports suggested that an 
ultrasound probe placed on the perineum and traditional 
micturating cystourethrography had similar sensitivity 
and specificity in detecting urethral anomalies.88 Some 
infants might have dysplastic kidneys, and nuclear 
studies could prove useful, but rarely before 2 months of 
age. Notably, while the pop-off mechanism of unilateral 
vesicoureteral reflux has traditionally been thought to 
protect the contralateral renal unit from high pressure, 
more recent findings call this into question.89 
In a full-term baby, the standard of care for posterior 
urethral valves is circumcision to reduce the risk of 
infection and cystoscopic valve ablation. Hook cautery, 
cold knife, and laser energy90 are all effective. Adequacy 
of valve ablation might be difficult to assess initially as 
dilation often persists; a ratio of 2・5:1 or less between 
the width of the mid-posterior urethra on oblique 
fluoroscopic film and the maximum diameter of the 
bulbar urethra often indicates successful ablation.91 A 
high level of suspicion should remain for stricture or 
residual posterior urethral valves if bladder emptying 
is poor. Even withstanding a normal micturating 
cystourethrograph, 
cystosopy might reveal remnants of 
valves in up to 50% of patients.92 
In infants with extremely low birthweight, the urethra 
might be too small to admit cystoscopic equipment 
safely. Long-term catheter drainage is inadvisable 
because of the risk of candidaemia. Rather than risking 
stricture with cystoscopic instrumentation, these babies 
should either undergo open vesicostomy or the rarely 
used but effective Fogarty balloon valve ablation under 
fluoroscopic guidance.93 
Notwithstanding surgical relief of urethral obstruction, 
ongoing bladder dysfunction is both a cause of morbidity 
and potential threat to upper tract function. Up to 80% of 
vesicoureteral reflux will resolve after valve ablation.94 A 
small, contracted bladder in infancy that progresses to a 
large-capacity, poorly compliant bladder, often found in 
the presence of persistent upper tract dilation and 
nephrogenic diabetes insipidus, has been termed valve 
bladder.95,96 This can create a self-injurious cycle, with 
persistent dilation leading to a worsening renal 
concentrating defect and creating more work for a 
bladder at risk of muscular failure. Regular urodynamic 
monitoring is crucial in the management of these 
patients. 
Discussion 
Advances in paediatric urology have been remarkable, 
especially because innovations and randomised controlled 
trials are difficult to implement in the paediatric 
population and because diseases are heterogeneous. In 
the coming years, refinements in fetal diagnosis and 
interventions and the introduction of regenerative 
medicine and tissue engineering for bladder 
reconstruction can be anticipated. The benefits of 
minimally invasive surgery and robot-assisted surgery 
compared with conventional surgery and non-operative 
treatments needs to be defined through large, multicentre, 
randomised controlled trials. The importance of a smooth 
transition of care from paediatric urology to adult urology 
cannot be overemphasised. Many challenges remain, but 
research and innovations will be rewarding as the benefits 
for patients will be lifelong. 
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